Janux Therapeutics Income Statement (2020-2025) | JANX

1Y3Y5Y7Y10YAll
Download Data
Income Statement Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue -0.10M0.38M0.48M1.16M1.62M1.59M2.37M1.81M2.85M2.05M1.06M2.52M2.46M1.25M8.90M0.44M10.00M
Operating items
Research & Development 0.55M0.83M0.98M1.93M4.74M8.41M11.17M10.18M14.09M13.74M15.43M15.87M14.92M11.89M12.24M14.07M14.90M18.61M20.81M25.05M34.66M34.63M
Selling, General & Administrative 0.28M0.42M0.67M0.74M2.00M3.66M3.94M4.95M5.54M6.10M5.68M6.46M6.88M6.44M6.36M7.34M7.82M17.67M8.22M9.84M10.45M10.62M
Operating Expenses 0.83M1.26M1.66M2.66M6.73M12.06M15.11M15.13M19.63M19.84M21.11M22.33M21.80M18.33M18.60M21.41M22.72M36.28M29.02M34.90M45.12M45.25M
Operating Income -0.83M-1.26M-1.66M-2.28M-6.25M-10.90M-13.49M-13.54M-17.26M-18.02M-18.27M-20.28M-20.75M-15.81M-16.14M-20.16M-13.82M-35.84M-29.02M-34.90M-45.12M-35.25M
EBIT -0.83M-1.26M-1.66M-2.28M-6.25M-10.90M-13.49M-13.54M-17.26M-18.02M-18.27M-20.28M-20.75M-15.81M-16.14M-20.16M-13.82M-35.84M-29.02M-34.90M-45.12M-35.25M
Non-operating items
Interest & Investment Income 0.05M0.14M0.07M0.13M0.37M1.33M2.20M2.82M3.24M4.25M4.38M5.40M7.86M7.78M8.81M11.39M11.26M10.94M
Non Operating Income -0.59M0.05M0.14M0.07M0.13M0.37M1.33M2.20M2.82M3.24M4.25M4.38M5.40M7.86M7.78M8.81M11.39M11.26M10.94M
Net income details
EBT -0.92M-1.26M-1.66M-2.28M-6.21M-10.77M-13.42M-13.41M-16.89M-16.70M-16.07M-17.46M-17.51M-11.57M-11.76M-14.76M-5.96M-28.06M-20.22M-23.51M-33.86M-24.31M
Profit After Tax -1.41M-1.26M-1.66M-2.28M-6.21M-10.77M-13.42M-13.41M-16.89M-16.70M-16.07M-17.46M-17.51M-11.57M-11.76M-14.76M-5.96M-28.06M-20.22M-23.51M-33.86M-24.31M
Income from Continuing Operations -0.92M-1.26M-1.66M-2.28M-6.21M-10.77M-13.42M-13.41M-16.89M-16.70M-16.07M-17.46M-17.51M-11.57M-11.76M-14.76M-5.96M-28.06M-20.22M-23.51M-33.86M-24.31M
Consolidated Net Income -0.92M-1.26M-1.66M-2.28M-6.21M-10.77M-13.42M-13.41M-16.89M-16.70M-16.07M-17.46M-17.51M-11.57M-11.76M-14.76M-5.96M-28.06M-20.22M-23.51M-33.86M-24.31M
Income towards Parent Company -0.92M-1.26M-1.66M-2.28M-6.21M-10.77M-13.42M-13.41M-16.89M-16.70M-16.07M-17.46M-17.51M-11.57M-11.76M-14.76M-5.96M-28.06M-20.22M-23.51M-33.86M-24.31M
Net Income towards Common Stockholders -0.92M-1.26M-1.66M-2.28M-6.21M-10.77M-13.42M-13.41M-16.89M-16.70M-16.07M-17.46M-17.51M-11.57M-11.76M-14.76M-5.96M-28.06M-20.22M-23.51M-33.86M-24.31M
Additional items
EPS (Basic) -1.76-1.33-1.62-2.06-0.62-0.26-0.29-0.32-0.41-0.40-0.39-0.42-0.42-0.25-0.24-0.30-0.11-0.51-0.35-0.38-0.55-0.39
EPS (Weighted Average and Diluted) -0.90-0.26-0.29-0.32-0.41-0.40-0.39-0.42-0.42-0.25-0.24-0.30-0.11-0.51-0.35-0.38-0.55-0.39
Shares Outstanding (Weighted Average) 38.00M38.00M41.61M41.61M41.62M41.63M41.66M41.66M41.83M41.83M46.14M46.17M51.66M51.85M52.16M52.48M59.11M59.18M60.09M
Shares Outstanding (Diluted Average) 10.03M41.13M23.53M41.32M41.45M41.53M41.47M41.76M41.84M45.71M44.02M49.05M54.45M54.63M53.75M61.79M61.90M62.02M
EBITDA -1.41M-1.26M-1.66M-2.28M-6.19M-10.76M-13.71M-14.98M-17.23M-17.07M-15.32M-16.66M-17.83M-11.68M-9.92M-15.95M-7.05M-18.61M-25.88M-21.91M-33.87M-23.50M
Interest Expenses 0.10M
Shares Outstanding 0.92M0.97M1.05M1.23M41.09M41.17M41.24M41.39M41.50M41.55M41.62M41.80M41.87M46.15M46.25M51.84M52.16M52.34M59.06M59.17M59.30M60.12M